Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Hong Kong · Delayed Price · Currency is HKD 0.1070
-0.0020 (-1.83%)
Jul 31, 2026, 2:57 PM HKT
HKG:8329 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 180 | 267 | 274 | 275 | 289 | 310 | |
Market Cap Growth | -35.54% | -2.45% | -0.61% | -4.65% | -7.03% | -46.38% |
Enterprise Value | 91 | 305 | 74 | 165 | 130 | 154 |
Last Close Price | 0.11 | 0.16 | 0.09 | 0.09 | 0.09 | 0.10 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 10.28 | 10.35 | 4.70 | 7.03 |
PS Ratio | 0.17 | 0.25 | 0.25 | 0.24 | 0.26 | 0.30 |
PB Ratio | 0.23 | 0.34 | 0.25 | 0.25 | 0.25 | 0.27 |
P/TBV Ratio | 0.31 | 0.45 | 0.34 | 0.35 | 0.38 | 0.41 |
P/FCF Ratio | 1.26 | 1.87 | 48.65 | 6.49 | 6.15 | - |
P/OCF Ratio | 1.16 | 1.72 | 10.53 | 4.65 | 4.17 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.08 | 0.28 | 0.07 | 0.14 | 0.12 | 0.15 |
EV/EBITDA Ratio | 1.52 | 5.69 | 1.09 | 1.96 | 1.01 | 2.06 |
EV/EBIT Ratio | 3.96 | 13.30 | 1.99 | 3.10 | 1.35 | 3.51 |
EV/FCF Ratio | 0.64 | 2.13 | 13.09 | 3.88 | 2.78 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.11 |
Debt / EBITDA Ratio | 1.36 | 1.36 | 1.52 | 1.10 | 0.77 | 1.61 |
Debt / FCF Ratio | 0.57 | 0.57 | 19.96 | 2.33 | 2.23 | - |
Net Debt / Equity Ratio | -0.19 | -0.19 | -0.17 | -0.29 | -0.26 | -0.22 |
Net Debt / EBITDA Ratio | -2.83 | -2.83 | -2.81 | -3.84 | -2.25 | -3.37 |
Net Debt / FCF Ratio | -1.06 | -1.06 | -33.69 | -7.60 | -6.20 | 2.52 |
Asset Turnover | 0.79 | 0.79 | 0.74 | 0.74 | 0.72 | 0.69 |
Inventory Turnover | 3.75 | 3.75 | 3.47 | 3.06 | 3.01 | 3.38 |
Quick Ratio | 1.45 | 1.45 | 1.70 | 1.84 | 1.52 | 1.62 |
Current Ratio | 2.01 | 2.01 | 2.38 | 2.51 | 2.17 | 2.21 |
Return on Equity (ROE) | -6.14% | -6.14% | 1.35% | 1.44% | 6.55% | 3.73% |
Return on Assets (ROA) | 1.05% | 1.05% | 1.54% | 2.10% | 3.88% | 1.84% |
Return on Invested Capital (ROIC) | 3.62% | 2.91% | 2.05% | 3.10% | 8.92% | 5.10% |
Return on Capital Employed (ROCE) | 2.80% | 2.80% | 3.30% | 4.60% | 8.20% | 3.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -25.25% | -16.99% | 9.73% | 9.66% | 21.29% | 14.22% |
FCF Yield | 79.51% | 53.51% | 2.05% | 15.40% | 16.27% | -32.28% |
Dividend Yield | - | - | 5.91% | - | - | - |
Total Shareholder Return | - | - | 5.91% | - | - | - |